ATLANTA — Wearable activity monitors, such as the Apple Watch, provide objective, continuous activity data that correlate with established patient-reported outcomes for cancer patients, according to a poster presentation by Mayo Clinic researchers at the recent American Society of Hematology annual meeting in Atlanta.

“Cancer patients receive complex medical care, including surgery, radiation, chemotherapy and targeted agents that may result in physical, emotional, financial and spiritual consequences that can negatively impact quality of life and the ability to perform certain activities without help,” said lead author Dr. Carrie Thompson, a hematologist at Mayo Clinic. “These quality of life factors play an important role in predicting survival and determining the best treatment options.”

Thompson said gauging a patient’s qualify of life and performance status can be challenging, because it typically involves completing lengthy paper questionnaires, which can be burdensome for patients and may be inaccurate.

“In our study, we wanted to determine if wearable technology data could be correlated with traditional, validated patient-reported outcome measures in cancer patients,” Thompson said.

Researchers recruited 115 patients with lymphoma and multiple myeloma at Mayo Clinic with an expected life span of less than five years who owned an Apple iPhone version 5.0 or greater. All patients were provided with an Apple Watch and downloaded a study app onto the iPhone and watch at enrollment. Researchers collected baseline data on the iPhone, including questions regarding physical function, fatigue, sleep, social role, function and quality of life.

In addition, researchers developed two electronic emoji scales to measure quality of life.

“Emoji are a near universal, popular form of communication, understandable by diverse populations, including those with low health literacy,” Thompson said. “There are several studies that attempt to predict individual well-being based on analysis of social media postings on Facebook and Twitter, but these studies do not focus on emojis as a mechanism for patients to express how they are feeling on a given day. If we can demonstrate that simple emojis are a valid and reliable measure of patient well-being, it could revolutionize the way patient well-being assessments are accomplished.”

During the first week of the study, patients wore the watch for an average of 9.3 hours per day, took 3,760 mean steps per day, exercised 8.3 minutes per day, were sedentary 224.9 minutes per day, and burned 115.8 kilocalories per day.

Researchers observed significant associations between standard patient-reported outcome measures and activity data. The strongest correlation was between steps per day and the Patient-Reported Outcomes Measurement Information System physical function scoring system. In addition, researchers found that patients’ emoji responses were significantly associated with standard patient reported outcomes.

“While further research is needed to validate the use of wearable activity monitors in cancer care, we believe this technology has the potential to improve the way we care for patients,” Thompson said. “In the future, it may be possible to monitor patient symptoms and communicate with patients between appointments via wearable technology.”